Advertisement
IQV vs OSUR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IQV is a StrongBuy and OSUR is a Hold.
IQV in +5.27% Uptrend, rising for three consecutive days on November 09, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where IQV advanced for three days, in 186 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
Technical Analysis (Indicators)
Bullish Trend Analysis
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 67 cases where IQV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 67%.
The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IQV as a result. In 53 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.
The Moving Average Convergence Divergence Histogram (MACD) for IQV turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 26 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.
IQV moved below its 50-day moving average on November 13, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IQV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
IQV broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 16 (best 1 - 100 worst), indicating outstanding price growth. IQV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 32 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 43 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.251) is normal, around the industry mean (67.298). P/E Ratio (33.477) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (0.985) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.693) is also within normal values, averaging (9.775).
The Tickeron Profit vs. Risk Rating rating for this company is 91 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IQV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
Aroon Indicator for OSUR shows an upward move is likely
OSUR's Aroon Indicator triggered a bullish signal on October 15, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 138 similar instances where the Aroon Indicator showed a similar pattern. In 105 of the 138 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 63 cases where OSUR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
Following a +8.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where OSUR advanced for three days, in 178 of 257 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OSUR as a result. In 70 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The Moving Average Convergence Divergence Histogram (MACD) for OSUR turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 31 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.
OSUR moved below its 50-day moving average on November 02, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for OSUR crossed bearishly below the 50-day moving average on November 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OSUR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
OSUR broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.747) is normal, around the industry mean (4.964). P/E Ratio (-4.986) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (0.390) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.195) is also within normal values, averaging (56.876).
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. OSUR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OSUR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
IQV | OSUR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 19 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 77 Overvalued | 40 Fair valued | |
PROFIT vs RISK RATING 1..100 | 91 | 100 | |
SMR RATING 1..100 | 43 | 94 | |
PRICE GROWTH RATING 1..100 | 16 | 44 | |
P/E GROWTH RATING 1..100 | 32 | 30 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
OSUR's Valuation (40) in the Medical Specialties industry is somewhat better than the same rating for IQV (77) in the Servicestothe Health Industry industry. This means that OSUR’s stock grew somewhat faster than IQV’s over the last 12 months.
IQV's Profit vs Risk Rating (91) in the Servicestothe Health Industry industry is in the same range as OSUR (100) in the Medical Specialties industry. This means that IQV’s stock grew similarly to OSUR’s over the last 12 months.
IQV's SMR Rating (43) in the Servicestothe Health Industry industry is somewhat better than the same rating for OSUR (94) in the Medical Specialties industry. This means that IQV’s stock grew somewhat faster than OSUR’s over the last 12 months.
IQV's Price Growth Rating (16) in the Servicestothe Health Industry industry is in the same range as OSUR (44) in the Medical Specialties industry. This means that IQV’s stock grew similarly to OSUR’s over the last 12 months.
OSUR's P/E Growth Rating (30) in the Medical Specialties industry is in the same range as IQV (32) in the Servicestothe Health Industry industry. This means that OSUR’s stock grew similarly to IQV’s over the last 12 months.
| IQV | OSUR | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 2 days ago 67% | 2 days ago 75% |
| Momentum ODDS (%) | 2 days ago 68% | 2 days ago 78% |
| MACD ODDS (%) | 2 days ago 62% | 2 days ago 74% |
| TrendWeek ODDS (%) | 2 days ago 65% | 2 days ago 72% |
| TrendMonth ODDS (%) | 2 days ago 67% | 2 days ago 77% |
| Advances ODDS (%) | 6 days ago 62% | 3 days ago 69% |
| Declines ODDS (%) | 2 days ago 64% | 13 days ago 80% |
| BollingerBands ODDS (%) | 2 days ago 61% | 2 days ago 79% |
| Aroon ODDS (%) | N/A | 2 days ago 76% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IQV’s FA Score shows that 2 FA rating(s) are green while OSUR’s FA Score has 1 green FA rating(s).
- IQV’s FA Score: 2 green, 3 red.
- OSUR’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IQV’s TA Score shows that 1 TA indicator(s) are bullish while OSUR’s TA Score has 3 bullish TA indicator(s).
- IQV’s TA Score: 1 bullish, 6 bearish.
- OSUR’s TA Score: 3 bullish, 6 bearish.
Price Growth
IQV (@Medical Specialties) experienced а -2.47% price change this week, while OSUR (@Pharmaceuticals: Other) price change was +5.23% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -1.79%. For the same industry, the average monthly price growth was -7.29%, and the average quarterly price growth was +34.42%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.79%. For the same industry, the average monthly price growth was +4.31%, and the average quarterly price growth was +18.71%.
Reported Earning Dates
IQV is expected to report earnings on Feb 11, 2027.
OSUR is expected to report earnings on Mar 02, 2027.
Industries' Descriptions
@Medical Specialties (-1.79% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Pharmaceuticals: Other (+1.79% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
IQV and
Correlation & Price change
A.I.dvisor indicates that over the last year, IQV has been closely correlated with CRL. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then CRL could also see price increases.
| Ticker / NAME | Correlation To IQV | 1D Price Change % | ||
|---|---|---|---|---|
| IQV | 100% | -2.21% | ||
| CRL - IQV | 71% Closely correlated | -0.83% | ||
| TMO - IQV | 67% Closely correlated | +0.11% | ||
| RVTY - IQV | 59% Loosely correlated | -1.67% | ||
| A - IQV | 58% Loosely correlated | +0.55% | ||
| ICLR - IQV | 54% Loosely correlated | -2.92% | ||
More | ||||
OSUR and
Correlation & Price change
A.I.dvisor indicates that over the last year, OSUR has been loosely correlated with IQV. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if OSUR jumps, then IQV could also see price increases.
| Ticker / NAME | Correlation To OSUR | 1D Price Change % | ||
|---|---|---|---|---|
| OSUR | 100% | N/A | ||
| IQV - OSUR | 43% Loosely correlated | -2.21% | ||
| MTD - OSUR | 42% Loosely correlated | +0.46% | ||
| RVTY - OSUR | 41% Loosely correlated | -1.67% | ||
| IART - OSUR | 41% Loosely correlated | +0.35% | ||
| INGN - OSUR | 38% Loosely correlated | +1.25% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| HEWJ | 62.70 | 0.13 | +0.21% |
| iShares Currency Hedged MSCI Japan ETF (HEWJ) | |||
| SPTS | 28.66 | 0.01 | +0.03% |
| State Street SPDR Portfolio Short Term Treasury ETF (SPTS) | |||
| KDVD | 29.98 | N/A | N/A |
| Keeley Dividend ETF (KDVD) | |||
| FEIG | 38.79 | -0.08 | -0.21% |
| Northern Trust ESG & Climate Investment Grade Corporate Core ETF (FEIG) | |||
| BKCH | 45.56 | -1.84 | -3.88% |
| Global X Blockchain ETF (BKCH) | |||